Ergomed PLC operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ergomed PLC with three other
miscellaneous service companies in Europe:
Oxford BioMedica plc
sales of £64.06 million [US$85.53 million]
of which 80%
(69.78 million Euros [US$83.27 million]
of which 40%
was Milestone Payments), and
based in GERMANY
(71.76 million Euros [US$85.63 million]
of which 52%
was Partnered Discovery).
During the year ended December of 2019, sales at
Ergomed PLC were £68.26 million (US$91.13 million).
increase of 26.1%
versus 2018, when the company's sales were £54.11 million.
This was the fifth consecutive year of sales increases at Ergomed PLC
(and since 2014, sales have increased a total of 223%).